-
Mashup Score: 4
A 69-year-old man with a history notable for nonmelanoma skin cancer and being a nonsmoker sought dermatologic evaluation for a persistent, nonhealing lesion on his right lower lip.
Source: www.hmpgloballearningnetwork.comCategories: General Medicine News, DermatologyTweet
-
Mashup Score: 0Cabozantinib Shows Promising Activity Among Patients With Progressive, Unresectable Metastatic Phaeochromocytomas and Paragangliomas - 5 day(s) ago
According to results from the phase 2 Natalie trial, cabozantinib showed promising clinical activity among patients with progressive, unresectable metastatic phaeochromocytomas and paragangliomas.
Source: www.hmpgloballearningnetwork.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 11Interventional Cardiologists’ Perspectives and Knowledge Towards Artificial Intelligence - 5 day(s) ago
The authors conducted a global, web-based, anonymous survey of interventional cardiology fellows and attendings to assess the knowledge and perceptions of interventional cardiologists regarding artificial intelligence use in interventional cardiology.
Source: www.hmpgloballearningnetwork.comCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 1Topical Medications in Atopic Dermatitis: Updates and Insights from Latest Guidelines - 6 day(s) ago
In this interview, Dr Eichenfield outlines key recommendations and updates from the latest guidelines for managing atopic dermatitis with topical medications.
Source: www.hmpgloballearningnetwork.comCategories: General Medicine News, DermatologyTweet
-
Mashup Score: 0
According to interim analysis results from the phase 3 KEYNOTE-564 trial, adjuvant pembrolizumab significantly improved overall survival compared to placebo among patients with clear-cell renal cell carcinoma at increased risk of recurrence after surgical resection.
Source: www.hmpgloballearningnetwork.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 3
In this feature Dermatology Week video, Dr Peter Lio discusses what his session, “Alternative and Complementary Dermatology: Educating Patients,” will cover during the meeting.
Source: www.hmpgloballearningnetwork.comCategories: General Medicine News, DermatologyTweet
-
Mashup Score: 0
In this video from ISET 2024, Ramon Varcoe, MBBS, MS, PhD, MMed (ClinEpi), discusses his presentation on the LIFE-BTK study.
Source: www.hmpgloballearningnetwork.comCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 0FDA Approves Tisotumab Vedotin for Patients With Recurrent or Metastatic Cervical Cancer - 7 day(s) ago
Based on results from the phase 3 innovaTV 301 trial, the FDA has approved tisotumab vedotin for patients with recurrent or metastatic cervical cancer who experienced disease progression on or after systemic treatment.
Source: www.hmpgloballearningnetwork.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0
Results from the phase 2 NRG Oncology/GOG Study 279 found that gemcitabine plus cisplatin concurrently administered with intensity-modulated radiation therapy improved complete pathologic response among patients with locally advanced, unresectable vulvar squamous cell carcinoma.
Source: www.hmpgloballearningnetwork.comCategories: General Medicine News, Onc News and JournalsTweet-
According to Neil Horowitz, MD, and coauthors, "compared with historic results, the addition of gemcitabine to cisplatin once per week given concurrently with [intensity-modulated RT] significantly improved the [pCR]." Learn more: https://t.co/aSZNAGXIiY #medtwitter #onctwitter https://t.co/4A9aDPWVOZ
-
-
Mashup Score: 2
At the Great Debates and Updates in Lung Cancer Meeting in New York, New York, Jamie Chaft, MD, argued in favor of both pre- and post-operative immunotherapy in the treatment of lung cancer.
Source: www.hmpgloballearningnetwork.comCategories: General Medicine News, Onc News and JournalsTweet
Uncover the mystery behind this nodular, ulcerated lesion on the lower mucosal lip in a 69-year-old man with a history of nonmelanoma skin cancer. What could be the diagnosis?https://t.co/0ns8INMTf4 #CaseReport #MedicalMystery #DermTwitter #Dermatology #Dermatologist #DermInsight